Stock 688293 SHANGHAI OPM BIOSCIENCES CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

News Shanghai OPM Biosciences Co., Ltd.

Equities

688293

CNE100005PF1

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-04-29 pm EDT 		5-day change 1st Jan Change
37.81 CNY +2.77% Intraday chart for Shanghai OPM Biosciences Co., Ltd. +13.37% -31.47%
Apr. 29 Shanghai OPM Biosciences Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 02 Tranche Update on Shanghai OPM Biosciences Co., Ltd.'s Equity Buyback Plan announced on October 31, 2023. CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Shanghai OPM Biosciences Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Tranche Update on Shanghai OPM Biosciences Co., Ltd.'s Equity Buyback Plan announced on October 31, 2023.
CI
Shanghai OPM Biosciences Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Tranche Update on Shanghai OPM Biosciences Co., Ltd.'s Equity Buyback Plan announced on October 31, 2023.
CI
Shanghai OPM Biosciences Co., Ltd. announces an Equity Buyback for CNY 100 million worth of its shares.
CI
Shanghai OPM Biosciences Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Shanghai OPM Biosciences Co., Ltd. authorizes a Buyback Plan.
CI
Shanghai Opm Biosciences Chairman Raises Stake
MT
Shanghai OPM Biosciences Co., Ltd.(SHSE:688293) added to Shanghai Stock Exchange Composite Index
CI
Shanghai OPM Biosciences Co., Ltd.(SHSE:688293) added to Shanghai Stock Exchange A Share Index
CI
Shanghai OPM Biosciences Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Certain A Shares of Shanghai OPM Biosciences Co., Ltd. are subject to a Lock-Up Agreement Ending on 25-AUG-2023.
CI
Shanghai OPM Biosciences Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Shanghai OPM Biosciences Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Shanghai OPM Biosciences Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
Shanghai OPM Bioengineering Co., Ltd. announced that it expects to receive CNY 321.43 million in funding from Shanghai OPM Biosciences Co., Ltd.
CI
Shanghai OPM Biosciences Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 688293 Stock
  4. News Shanghai OPM Biosciences Co., Ltd.